Melanoma: all 3,073 studies

Page 2 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.

• Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) StudyNot yet recruitingNCT07389525Early Phase 1
• Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma PatientsRecruitingNCT07379138Not applicable
• A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid TumorsRecruitingNCT07376707Phase 1
• Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle AnalysisNot yet recruitingNCT07376512
• An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsRecruitingNCT07371663Phase 1/2
• COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot StudyRecruitingNCT07354152
• Early Detection of Skin Tumors Using a Telemedicine Tool in Primary CareRecruitingNCT07349940Not applicable
• Neoadjuvant Pembrolizumab in Patients With Stage IIb/c MelanomaRecruitingNCT07349303Phase 2
• SL-28 for Advanced Solid TumoursRecruitingNCT07341737Phase 1/2
• Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.Not yet recruitingNCT07340619Phase 2
• Intratumoral N17350 in Advanced Solid TumorsRecruitingNCT07339176Phase 1/2
• Natural History Study of Early Life Exposures in Agriculture (ELEA)Enrolling by invitationNCT07328516
• Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)RecruitingNCT07327489
• CARE-Melanoma TrialNot yet recruitingNCT07320222Phase 1
• Sample Collection for Ongoing Research and Product Evaluation StudyRecruitingNCT07318051
• A Phase 1 Study of JMT108 in Participants With Advanced Solid TumorsRecruitingNCT07317505Phase 1
• Contrast-enhanced Ultrasound for Sentinel Node DetectionRecruitingNCT07310758Phase 2/3
• Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021RecruitingNCT07302607
• Investigation of the ROle of faT and inflAmmaTory Cells in mElanomaNot yet recruitingNCT07293598
• DOC1021 Dendritic Cell Immunotherapy for Refractory MelanomaRecruitingNCT07288112Phase 1/2
• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsRecruitingNCT07287917Phase 1/2
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
• Hepzato Kit and Opdualag for Metastatic Melanoma and Liver MetastasisRecruitingNCT07281924Phase 1/2
• Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract TumorsRecruitingNCT07280832Phase 1/2
• Investigating Real-Time Immunotherapy Symptoms StudyRecruitingNCT07280715Not applicable
• Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic LesionsRecruitingNCT07277920
• Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank HuidkankerRecruitingNCT07266142
• VSV-02 Compassionate Use in Advanced Solid TumorsRecruitingNCT07260591Phase 1
• Study of ACC-1898 in Adult Participants With Advanced Solid TumorsNot yet recruitingNCT07252661Phase 1
• Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL CriteriaRecruitingNCT07251335
• Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry AnalysisNot yet recruitingNCT07246759
• A Study of DEG6498 in Participants With Solid TumorsRecruitingNCT07244835Phase 1
• IL-17 Blockade to Decrease irAEs (REPLAY)RecruitingNCT07237594Phase 1
• Mirdametinib in Patients With Advanced NF1-mutant MelanomaRecruitingNCT07237100Phase 2
• Neo-adjuvant Immunotherapy in Patients With Localized MelanomaRecruitingNCT07230613Phase 2
• Promoting Immunotherapy Efficacy With Low-Dose Liver RTRecruitingNCT07225036Not applicable
• A Study of BI 3810944 in Patients With Advanced CancerRecruitingNCT07224425Phase 1
• Patient Preference for Subcutaneous vs. Intravenous Immune TherapyRecruitingNCT07223424Phase 2
• Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] MelanomaRecruitingNCT07221734Phase 3
• [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in CancerRecruitingNCT07215182Phase 2
• Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.RecruitingNCT07206017Not applicable
• Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic MelanomaNot yet recruitingNCT07183852Phase 1
• A Study of DXC014 in Patients With Advanced Solid Tumors.RecruitingNCT07177937Phase 1
• Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint InhibitorsRecruitingNCT07161310Not applicable
• Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME TrialRecruitingNCT07155317Phase 2
• Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous MelanomaRecruitingNCT07148245
• AI-Driven Early Detection of Skin CancerRecruitingNCT07144306
• IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With MelanomaRecruitingNCT07138222
• Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint BlockadeRecruitingNCT07130032Phase 2
• DESTINY-PANTUMOUR04RecruitingNCT07124000
• A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsRecruitingNCT07115043Phase 1/2
• Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy VolunteersNot yet recruitingNCT07114172Not applicable
• Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic MelanomaRecruitingNCT07112170Not applicable
• A Study of GV20-0251 in Advanced or Refractory Solid TumorsRecruitingNCT07106827Phase 1
• MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.RecruitingNCT07092670
• A Study to Evaluate Adze1.C in Participants With Metastatic MelanomaRecruitingNCT07086105Phase 1
• Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderRecruitingNCT07072728Phase 2
• An International Study on Pediatric Patients With Rare Tumors.RecruitingNCT07072143
• Study of GV20-0251 in Participants With Solid Tumor MalignanciesRecruitingNCT07070518Phase 1/2
• A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsRecruitingNCT07070232Phase 1/2
• Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage MelanomaRecruitingNCT07068074Phase 3
• Neoadjuvant Tebentafusp in Patients With Metastatic Uveal MelanomaRecruitingNCT07057596Phase 2
• Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma StudyRecruitingNCT07050940Not applicable
• The Multicentre Selective Lymphadenectomy Trial - 3RecruitingNCT07049276Not applicable
• The Florida ASCENT StudyRecruitingNCT07042243Not applicable
• Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1Not yet recruitingNCT07040436Phase 1/2
• APA (Adapted Physical Activity) for Patients With Advanced MelanomaRecruitingNCT07031830
• Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint InhibitorsNot yet recruitingNCT07028008Not applicable
• Neoadjuvant Darovasertib in Primary Uveal MelanomaRecruitingNCT07015190Phase 3
• Clinical Genetics Branch Eligibility Screening SurveyNot yet recruitingNCT07005297
• Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical StudyNot yet recruitingNCT07004335Phase 4
• Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)RecruitingNCT06999980Phase 2
• Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.RecruitingNCT06994208
• Reducing Symptom Burden Through Physical Exercise in Melanoma PatientsRecruitingNCT06985056Not applicable
• Video-Tumorboard PLUSRecruitingNCT06980740
• Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without ImmunotherapyNot yet recruitingNCT06976021Phase 2
• Resistance Exercise in Patients With Ocular MelanomaRecruitingNCT06970236Not applicable
• Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic CancersRecruitingNCT06967961Not applicable
• Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II TrialRecruitingNCT06965231Phase 2
• Clinical Trial of CD40L-augmented TIL for Patients With Advanced MelanomaRecruitingNCT06961357Phase 1/2
• A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)RecruitingNCT06961006Phase 2
• A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid TumorsRecruitingNCT06956690Phase 1/2
• DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsRecruitingNCT06953089Phase 2
• The Registry Study of Genetic Alterations of Melanoma in TaiwanRecruitingNCT06952400
• ACTengine® IMA203 Combined With mRNA-4203RecruitingNCT06946225Phase 1
• An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid TumorsRecruitingNCT06942143Phase 1
• A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive LifileucelRecruitingNCT06940739Phase 1/2
• IDOV-Immune for Advanced Solid TumorsRecruitingNCT06910657Phase 1
• NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and SarcomaRecruitingNCT06889766Phase 1
• A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3RecruitingNCT06887348
• Encorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Symptomatic Brain MetastasesRecruitingNCT06887088Phase 2
• A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid TumorsRecruitingNCT06880549Phase 1
• Review of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for MelanomaRecruitingNCT06861023
• A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma TreatmentEnrolling by invitationNCT06848088Phase 2
• A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced MalignanciesRecruitingNCT06839105Phase 1
• Evaluation of Hypoxia in Primary MelanomaRecruitingNCT06831071
• Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsRecruitingNCT06814496Phase 1/2
• A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic TherapyRecruitingNCT06797297Phase 2
• SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III MelanomaRecruitingNCT06794775Phase 3
• Investigation of the Performance of the Medical Device Dermalyser in Determining Melanoma Thickness Based on Dermoscopy ImagesNot yet recruitingNCT06788665

← Melanoma overview